Sort
48,018 grants matching “immunotherapy”
Integrin activator-adjuvanted DNA vaccine against Trypanosoma cruzi infection
$997,867Upendra Marathi · 7 Hills Pharma, Llc · R44 · FY2023 · AI
Integrin activator-adjuvanted DNA vaccine against Trypanosoma cruzi infection
$997,867Upendra Marathi · 7 Hills Pharma, Llc · R44 · FY2024 · AI
Modeling the ecology of tissue-resident T cells
$997,716Andrew Yates · Columbia University Health Sciences · U01 · FY2022 · AI
Scale-up manufacturing of microneedle stamp for peanut allergen immunotherapy
$997,668Samirkumar Patel · Moonlight Therapeutics, Inc. · SB1 · FY2025 · AI
A Novel PET Probe for Use in Cancer Diagnostics
$997,667Melissa Moore · Sofie Biosciences, Inc. · R44 · FY2017 · CA
Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer
$997,515Valerie Humblet · Collagen Medical, Llc · R44 · FY2016 · CA
New Class of Bright, Sharp, Tunable Near-Infrared Fluorophores for Flow Cytometry
$997,404Christopher J Macnevin · Nirvana Sciences, Inc. · R44 · FY2020 · AI
Targeting Epigenetic Circuits in B-Cell Lymphomas
$996,660Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R35 · FY2022 · CA
Biology and genetics of metastatic disease
$996,660Sohail F. Tavazoie · Rockefeller University · R35 · FY2023 · CA
Molecular mechanisms of antibody-mediated immunotherapies
$996,658Jeffrey Victor Ravetch · Rockefeller University · R35 · FY2022 · CA
Modeling Combination Immunotherapy for HIV Cure in Humanized Mouse Models
$996,589James L Riley · University Of Pennsylvania · U19 · FY2020 · AI
Multi-Omic Single-Cell System for Improved Combination Cancer Immunotherapy Monitoring and Implementation
$996,470Timothy S McConnell · Isoplexis, Inc. · R44 · FY2019 · CA
Scale-up manufacturing of microneedle stamp for peanut allergen immunotherapy
$996,384Samirkumar Patel · Moonlight Therapeutics, Inc. · SB1 · FY2024 · AI
Molecular, Cellular, and Tissue Characterization Unit
$996,148William E Gillanders · Washington University · U2C · FY2018 · CA
Role of the microbiota in regulating the mononuclear phagocyte system
$996,061Silvana Goldszmid · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Safe and Efficacious Oral MIF Inhibitors for Rheumatoid Arthritis
$995,900Anderson Gaweco · Innovimmune Biotherapeutics Holding, Llc · R44 · FY2014 · AI
Safe and Efficacious Oral MIF Inhibitors for Rheumatoid Arthritis
$995,900Anderson Gaweco · Innovimmune Biotherapeutics Holding, Llc · R44 · FY2016 · AI
Safe and Efficacious Oral MIF Inhibitors for Rheumatoid Arthritis
$995,900Anderson Gaweco · Innovimmune Biotherapeutics Holding, Llc · R44 · FY2015 · AI
A Phase I Dose-escalation Study of Intraperitoneal CYN101 as Consolidation Immunotherapy in Women with Residual or Recurrent Ovarian Cancer Status after Chemotherapy
$995,814Scott Budd Winram · Cynvec, Llc · R44 · FY2016 · CA
Monoclonal Antibodies for Alzheimer's Immunotherapy
$995,765Andrew C Hiatt · Mapp Biopharmaceutical, Inc. · R44 · FY2009 · AG
Mechanisms and Optimal Combinations of Cisplatin Chemotherapy for Head and Neck Squamous Cell Carcinoma
$995,719Nicole Schmitt · National Institute On Deafness And Other Communication Disorders · ZIA · FY2019 · DC
Reprogramming of T cells for the Treatment of Melanoma
$995,664Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2014 · CA
Reprogramming of T cells for the Treatment of Melanoma
$995,664Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Reprogramming of T cells for the Treatment of Melanoma
$995,664Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2016 · CA
In vivo dose finding for IN-002 in neonatal lambs for inhaled immunotherapy of RSV
$995,652Richard A Cone · Mucommune, Llc · R44 · FY2021 · AI